Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study
8 months ago
By
In Clinical TrialsStartups
featured
New Zealand beat Australian Champions #2
9 months ago
By
In LeadersStartups
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease
10 months ago
By
In Breaking NewsBreakthroughsInnovationTop Stories
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis
10 months ago
By
In Clinical TrialsInnovationTop Stories
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic Advances in Rare Disease Pipeline and Clinical Progress
10 months ago
By
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America
10 months ago
By
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
10 months ago
By
In Biopharma ManufacturingInnovationLeadersPharma Industry Updates
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
10 months ago
By
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
10 months ago
By
In Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes
10 months ago
By
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects
10 months ago
By
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones
10 months ago
By
In Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management
10 months ago
By
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data
10 months ago
By
In Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease
11 months ago
By
In Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
AbbVie Provides Update on VERONA Trial Evaluating Venetoclax in Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
11 months ago
By
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
CSL’s ANDEMBRY™ Gains FDA Approval as First Prophylactic Therapy Targeting Factor XIIa for Hereditary Angioedema
11 months ago
By
In Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer
11 months ago
By
In Biopharma ManufacturingBreakthroughsClinical TrialsFDA ApprovalsIndustry ConferencesInnovationLeadersResearch UpdatesVenture Capital
ADC Therapeutics Shares Updated LOTIS-7 Clinical Trial Data Showing Strong Efficacy in Relapsed or Refractory Large B-Cell Lymphoma
11 months ago
By
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Presents Updated Positive Data for Xervyteg® in Acute Graft-versus-Host Disease at EHA Congress
11 months ago
By
In Clinical TrialsInnovationPharma Industry Updates
Innovative Biotech Collaborations and Cutting-Edge Clinical Data Spotlight June 11 Advances
11 months ago
By
In Clinical TrialsIndustry ConferencesInnovationPartnershipsPharma Industry UpdatesResearch Updates
Biotech Innovation and Clinical Advancements Define Mid-June as Industry Gears Up for Breakthroughs
11 months ago
By
In Clinical TrialsIndustry ConferencesInnovationPharma Industry UpdatesResearch Updates
Merck Gains FDA Approval for ENFLONSIA™ (clesrovimab) to Prevent RSV in Infants; George Medicines’ GMRx2 and AbbVie’s Mavyret Receive Label Expansions
11 months ago
By
In Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
June Biotech Momentum: Innovation, Regulatory Shifts, and Strategic Collaborations
11 months ago
By
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
June Pharma Highlights: Vaccine Panel Shake-up, Moderna Deal Fallout, and FDA’s AI Adoption
11 months ago
By
In Featured AnalysisInnovationLeadersPharma Industry Updates
Cell and Gene Therapy Advances Highlighted in Recent Trials and Industry Collaborations
11 months ago
By
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates